Source: MarketScreener

Ironwood Pharmaceuticals: Ironwood Pharmaceuticals : to Present at Upcoming September Investor Conferences

(marketscreener.com) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present corporate updates at two upcoming investor conferences in September: 2019 Wells Fargo Healthcare Conference on Wednesday, September 4, 2019 at 2:25 p.m. ET at the Westin Copley Place in Boston. 17th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2019...http://www.marketscreener.com/IRONWOOD-PHARMACEUTICALS-5933097/news/Ironwood-Pharmaceuticals-to-Present-at-Upcoming-September-Investor-Conferences-29125914/?utm_medium=RSS&utm_content=20190828

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Ironwood's latest SEC filings

Annual Revenue

Based on data from Ironwood's latest SEC filings

Employees

Mark Mallon's photo - CEO of Ironwood

CEO

Mark Mallon

CEO Approval Rating

88/100

Ironwood is a drug manufacturer that develops and markets medicines for the treatment of irritable bowel syndrome and ch... Read more